Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells

The role of invariant natural killer T (iNKT) cells in antitumor immunity has been studied extensively, and clinical trials in patients with advanced cancer have revealed a prolonged survival in some cases. In recent years, humanized blocking antibodies against co-stimulatory molecules such as PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamata, Toshiko, Suzuki, Akane, Mise, Naoko, Ihara, Fumie, Takami, Mariko, Makita, Yuji, Horinaka, Atsushi, Harada, Kazuaki, Kunii, Naoki, Yoshida, Shigetoshi, Yoshino, Ichiro, Nakayama, Toshinori, Motohashi, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099366/
https://www.ncbi.nlm.nih.gov/pubmed/27631416
http://dx.doi.org/10.1007/s00262-016-1901-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099366/
https://www.ncbi.nlm.nih.gov/pubmed/27631416
http://dx.doi.org/10.1007/s00262-016-1901-y

Ejemplares similares